Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Resolved | 2017-03-17 | 2017-05-10 | 3115 |
RATIO-IPRA SAL UDV | 0.5MG 2.5MG | SOLUTION | Resolved | 2017-03-17 | 2017-07-28 | 3137 |
TEVA-IPRATROPIUM STERINEBS | 0.025% | SOLUTION | Resolved | 2017-04-25 | 2017-10-10 | 8071 |
RATIO-IPRATROPIUM UDV | 250MCG | SOLUTION | Resolved | 2017-05-23 | 2017-09-19 | 10892 |
TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2017-05-23 | 2018-07-30 | 10911 |
TRISENOX | 1MG | SOLUTION | Resolved | 2017-07-14 | 2018-07-30 | 15753 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Resolved | 2017-08-01 | 2018-05-08 | 17779 |
TEVA-LACTULOSE | 667MG | SOLUTION | Resolved | 2017-08-21 | 2017-10-10 | 19964 |
DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2018-06-22 | 2018-10-11 | 52823 |
FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2018-08-21 | 2018-11-08 | 58634 |
ACT OLOPATADINE 0.2% | 0.2% | SOLUTION | Actual shortage | 2018-10-23 | 2018-10-23 | 65516 |
ACT OLOPATADINE 0.1% | 0.1% | SOLUTION | Actual shortage | 2018-10-23 | 2018-10-23 | 65519 |
EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2018-12-04 | 2019-08-06 | 68608 |
FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2019-02-05 | 2019-03-12 | 74792 |
FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2019-06-03 | 2019-08-07 | 85468 |
LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Resolved | 2019-06-13 | 2019-08-21 | 86601 |
OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2019-06-18 | 2019-08-06 | 86905 |
OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2019-06-18 | 2019-07-16 | 86908 |
TEVA-LATANOPROST | 0.05MG | SOLUTION | Resolved | 2019-06-18 | 2019-08-06 | 86930 |
CALMYLIN PSE WITH CODEINE | 30MG 3.3MG 100MG | SOLUTION | Resolved | 2019-06-27 | 2019-08-16 | 87659 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |
TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |